- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Genentech BRAF inhibitor
Total 68893 results
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
PrECOG, LLC.Genentech, Inc.Active, not recruitingMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Pierre Fabre MedicamentMerck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic Colorectal Cancer | BRAF V600EChina
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruitingNon-Small Cell Lung Cancer | Lung CancerUnited States
-
Howard S HochsterGenentech, Inc.; Rutgers Cancer Institute of New JerseyActive, not recruitingUnresectable Hepatocellular CarcinomaUnited States
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast CancerUnited States
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
Michael RothUniversity of California, Los Angeles; University of Michigan; Genentech, Inc.CompletedScleroderma, Systemic | Interstitial Lung DiseaseUnited States
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedGlioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditionsUnited States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Terminated
-
Columbia UniversityGenentech, Inc.; Celgene CorporationCompletedCarcinoma, Non-Small-Cell LungUnited States
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Mylin A. Torres, MDPfizer; Genentech, Inc.; Emory UniversityTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
St. Justine's HospitalCHU de Quebec-Universite Laval; Montreal Children's Hospital of the MUHCActive, not recruitingLow-grade Glioma | Plexiform Neurofibroma | Central Nervous System GliomaCanada
-
Arkadiusz Z. Dudek, MDGenentech, Inc.; Vanquish Oncology, Inc.; HealthPartners Regions Cancer Care... and other collaboratorsTerminatedUveal MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
Ludwig-Maximilians - University of MunichActive, not recruitingFOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC (AIO-KRK-0116)Metastatic Colorectal CancerGermany
-
Pierre Fabre MedicamentActive, not recruiting
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand PharmaceuticalsCompletedAdvanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)United States
-
Novartis PharmaceuticalsAvailable
-
Chandrikha ChandrasekharanAstraZeneca; Biocompatibles UK LtdSuspendedMetastatic Colorectal Cancer | Colorectal Neoplasms | Rectal Cancer | Colon Cancer | Colorectal Cancer Metastatic | Liver Metastases | Colo-rectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Liver Metastasis Colon CancerUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; AmgenCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
Massachusetts General HospitalIncyte CorporationTerminated
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
Genentech, Inc.CompletedProstate CancerUnited States, Spain, Czechia, France, Greece, Netherlands, United Kingdom, Romania, Italy
-
Fondazione Melanoma OnlusWithdrawn
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
Nabil AdraGenentech, Inc.; Indiana University School of MedicineTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Arnaud Bewley, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingSarcoma | Desmoplastic Small Round Cell Tumor (DSRCT)United States
-
University of NebraskaNational Cancer Institute (NCI); Genentech, Inc.Completed
-
Medical College of WisconsinGenentech, Inc.; Clovis Oncology, Inc.CompletedUterine Carcinosarcoma | Endometrial CancerUnited States
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Melanoma Institute AustraliaActive, not recruiting